ENDRA Life Sciences Inc. - 8-K Filing
ENDRA Life Sciences Inc. entered into a securities purchase agreement with an accredited investor for $3.8 million in gross proceeds through the sale of 578,387 shares and warrants to buy up to 1,156,774 additional shares at $6.57 per share. The company also signed a side letter requiring potential repayment if it does not pursue a strategic alternative with specified counterparties. Additionally, ENDRA believes the offering has restored its stockholders’ equity above Nasdaq’s minimum requirement of $2.5 million to avoid delisting. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $NDRA